Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Assurance Medical

This article was originally published in The Gray Sheet

Executive Summary

Completes $8 mil. private equity financing and spins off from UroMed Corporation as a fully independent entity to pursue development of breast cancer screening products. The firm's "electronic palpation" technology employs an array of highly sensitive pressure sensors to measure characteristics of breast tissue, Assurance explains. In 1997, the company received expedited review status from FDA for its BreastCheck device for home use. UroMed retains a minority equity position in the company. The financing was led by Frazier & Company and TL Ventures
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT011685

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel